nodes	percent_of_prediction	percent_of_DWPC	metapath
Anidulafungin—Infusion related reaction—Capecitabine—esophageal cancer	0.0803	0.0808	CcSEcCtD
Anidulafungin—Infusion site pain—Capecitabine—esophageal cancer	0.0461	0.0464	CcSEcCtD
Anidulafungin—Potassium low—Capecitabine—esophageal cancer	0.0361	0.0363	CcSEcCtD
Anidulafungin—Phlebitis—Carboplatin—esophageal cancer	0.0295	0.0297	CcSEcCtD
Anidulafungin—Amylase increased—Cisplatin—esophageal cancer	0.0216	0.0217	CcSEcCtD
Anidulafungin—Blood potassium decreased—Capecitabine—esophageal cancer	0.0199	0.02	CcSEcCtD
Anidulafungin—Prothrombin level increased—Capecitabine—esophageal cancer	0.0184	0.0186	CcSEcCtD
Anidulafungin—Deep vein thrombosis—Capecitabine—esophageal cancer	0.0124	0.0125	CcSEcCtD
Anidulafungin—Infection—Carboplatin—esophageal cancer	0.0124	0.0125	CcSEcCtD
Anidulafungin—Oral candidiasis—Capecitabine—esophageal cancer	0.0119	0.012	CcSEcCtD
Anidulafungin—Respiratory distress—Capecitabine—esophageal cancer	0.0119	0.012	CcSEcCtD
Anidulafungin—Hypomagnesaemia—Capecitabine—esophageal cancer	0.0119	0.012	CcSEcCtD
Anidulafungin—Hypercalcaemia—Capecitabine—esophageal cancer	0.0109	0.011	CcSEcCtD
Anidulafungin—Hyperkalaemia—Cisplatin—esophageal cancer	0.0101	0.0101	CcSEcCtD
Anidulafungin—Pleural effusion—Capecitabine—esophageal cancer	0.00988	0.00994	CcSEcCtD
Anidulafungin—Body temperature increased—Carboplatin—esophageal cancer	0.00987	0.00993	CcSEcCtD
Anidulafungin—Coagulopathy—Capecitabine—esophageal cancer	0.00972	0.00978	CcSEcCtD
Anidulafungin—Rigors—Capecitabine—esophageal cancer	0.00927	0.00933	CcSEcCtD
Anidulafungin—Deep vein thrombosis—Methotrexate—esophageal cancer	0.00926	0.00932	CcSEcCtD
Anidulafungin—Phlebitis—Cisplatin—esophageal cancer	0.00865	0.0087	CcSEcCtD
Anidulafungin—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00838	0.00843	CcSEcCtD
Anidulafungin—Blood bilirubin increased—Capecitabine—esophageal cancer	0.008	0.00805	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Cisplatin—esophageal cancer	0.0076	0.00765	CcSEcCtD
Anidulafungin—Injection site reaction—Capecitabine—esophageal cancer	0.00752	0.00757	CcSEcCtD
Anidulafungin—Pleural effusion—Methotrexate—esophageal cancer	0.00735	0.0074	CcSEcCtD
Anidulafungin—Candida infection—Capecitabine—esophageal cancer	0.00722	0.00727	CcSEcCtD
Anidulafungin—Blood creatinine increased—Cisplatin—esophageal cancer	0.00698	0.00702	CcSEcCtD
Anidulafungin—Dehydration—Cisplatin—esophageal cancer	0.00693	0.00697	CcSEcCtD
Anidulafungin—Hypokalaemia—Cisplatin—esophageal cancer	0.00678	0.00682	CcSEcCtD
Anidulafungin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00671	0.00675	CcSEcCtD
Anidulafungin—Sepsis—Capecitabine—esophageal cancer	0.00657	0.00661	CcSEcCtD
Anidulafungin—Caspofungin—ABCB1—esophageal cancer	0.00643	1	CrCbGaD
Anidulafungin—Phlebitis—Capecitabine—esophageal cancer	0.00637	0.00642	CcSEcCtD
Anidulafungin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00631	0.00635	CcSEcCtD
Anidulafungin—Sweating increased—Cisplatin—esophageal cancer	0.00627	0.00631	CcSEcCtD
Anidulafungin—Eye pain—Capecitabine—esophageal cancer	0.00608	0.00612	CcSEcCtD
Anidulafungin—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00595	0.00599	CcSEcCtD
Anidulafungin—Hot flush—Capecitabine—esophageal cancer	0.00587	0.00591	CcSEcCtD
Anidulafungin—Menopausal symptoms—Capecitabine—esophageal cancer	0.00582	0.00586	CcSEcCtD
Anidulafungin—Atrial fibrillation—Capecitabine—esophageal cancer	0.0058	0.00583	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Capecitabine—esophageal cancer	0.0056	0.00564	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00543	0.00546	CcSEcCtD
Anidulafungin—Blood creatinine increased—Capecitabine—esophageal cancer	0.00514	0.00518	CcSEcCtD
Anidulafungin—Dehydration—Capecitabine—esophageal cancer	0.00511	0.00514	CcSEcCtD
Anidulafungin—Urinary tract disorder—Cisplatin—esophageal cancer	0.00509	0.00512	CcSEcCtD
Anidulafungin—Liver function test abnormal—Capecitabine—esophageal cancer	0.00507	0.0051	CcSEcCtD
Anidulafungin—Connective tissue disorder—Cisplatin—esophageal cancer	0.00506	0.0051	CcSEcCtD
Anidulafungin—Urethral disorder—Cisplatin—esophageal cancer	0.00505	0.00508	CcSEcCtD
Anidulafungin—Abdominal pain upper—Capecitabine—esophageal cancer	0.00502	0.00505	CcSEcCtD
Anidulafungin—Hypokalaemia—Capecitabine—esophageal cancer	0.005	0.00503	CcSEcCtD
Anidulafungin—Visual impairment—Cisplatin—esophageal cancer	0.00497	0.005	CcSEcCtD
Anidulafungin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00495	0.00498	CcSEcCtD
Anidulafungin—Sepsis—Methotrexate—esophageal cancer	0.00489	0.00492	CcSEcCtD
Anidulafungin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00484	0.00487	CcSEcCtD
Anidulafungin—Eye disorder—Cisplatin—esophageal cancer	0.00482	0.00485	CcSEcCtD
Anidulafungin—Flushing—Cisplatin—esophageal cancer	0.00478	0.00481	CcSEcCtD
Anidulafungin—Cardiac disorder—Cisplatin—esophageal cancer	0.00478	0.00481	CcSEcCtD
Anidulafungin—Bronchospasm—Capecitabine—esophageal cancer	0.00467	0.0047	CcSEcCtD
Anidulafungin—Immune system disorder—Cisplatin—esophageal cancer	0.00466	0.00469	CcSEcCtD
Anidulafungin—Mediastinal disorder—Cisplatin—esophageal cancer	0.00464	0.00468	CcSEcCtD
Anidulafungin—Sweating increased—Capecitabine—esophageal cancer	0.00462	0.00465	CcSEcCtD
Anidulafungin—Erythema—Cisplatin—esophageal cancer	0.00449	0.00452	CcSEcCtD
Anidulafungin—Malnutrition—Cisplatin—esophageal cancer	0.00449	0.00452	CcSEcCtD
Anidulafungin—Neutropenia—Capecitabine—esophageal cancer	0.00444	0.00447	CcSEcCtD
Anidulafungin—Visual disturbance—Methotrexate—esophageal cancer	0.00431	0.00434	CcSEcCtD
Anidulafungin—Hyperglycaemia—Capecitabine—esophageal cancer	0.00428	0.00431	CcSEcCtD
Anidulafungin—Pneumonia—Capecitabine—esophageal cancer	0.00426	0.00428	CcSEcCtD
Anidulafungin—Infestation NOS—Capecitabine—esophageal cancer	0.00423	0.00426	CcSEcCtD
Anidulafungin—Infestation—Capecitabine—esophageal cancer	0.00423	0.00426	CcSEcCtD
Anidulafungin—Vision blurred—Cisplatin—esophageal cancer	0.00423	0.00426	CcSEcCtD
Anidulafungin—Depression—Capecitabine—esophageal cancer	0.00422	0.00425	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00417	0.0042	CcSEcCtD
Anidulafungin—Anaemia—Cisplatin—esophageal cancer	0.00415	0.00417	CcSEcCtD
Anidulafungin—Urinary tract infection—Capecitabine—esophageal cancer	0.00411	0.00414	CcSEcCtD
Anidulafungin—Leukopenia—Cisplatin—esophageal cancer	0.00402	0.00404	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.004	0.00403	CcSEcCtD
Anidulafungin—Convulsion—Cisplatin—esophageal cancer	0.00389	0.00391	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00379	0.00382	CcSEcCtD
Anidulafungin—Liver function test abnormal—Methotrexate—esophageal cancer	0.00377	0.0038	CcSEcCtD
Anidulafungin—Urinary tract disorder—Capecitabine—esophageal cancer	0.00375	0.00378	CcSEcCtD
Anidulafungin—Oedema peripheral—Capecitabine—esophageal cancer	0.00374	0.00377	CcSEcCtD
Anidulafungin—Connective tissue disorder—Capecitabine—esophageal cancer	0.00373	0.00376	CcSEcCtD
Anidulafungin—Urethral disorder—Capecitabine—esophageal cancer	0.00372	0.00375	CcSEcCtD
Anidulafungin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00366	0.00369	CcSEcCtD
Anidulafungin—Visual impairment—Capecitabine—esophageal cancer	0.00366	0.00368	CcSEcCtD
Anidulafungin—Infection—Cisplatin—esophageal cancer	0.00364	0.00366	CcSEcCtD
Anidulafungin—Nervous system disorder—Cisplatin—esophageal cancer	0.00359	0.00361	CcSEcCtD
Anidulafungin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00359	0.00361	CcSEcCtD
Anidulafungin—Skin disorder—Cisplatin—esophageal cancer	0.00356	0.00358	CcSEcCtD
Anidulafungin—Eye disorder—Capecitabine—esophageal cancer	0.00355	0.00357	CcSEcCtD
Anidulafungin—Hyperhidrosis—Cisplatin—esophageal cancer	0.00354	0.00356	CcSEcCtD
Anidulafungin—Flushing—Capecitabine—esophageal cancer	0.00353	0.00355	CcSEcCtD
Anidulafungin—Cardiac disorder—Capecitabine—esophageal cancer	0.00353	0.00355	CcSEcCtD
Anidulafungin—Angiopathy—Capecitabine—esophageal cancer	0.00345	0.00347	CcSEcCtD
Anidulafungin—Immune system disorder—Capecitabine—esophageal cancer	0.00343	0.00345	CcSEcCtD
Anidulafungin—Mediastinal disorder—Capecitabine—esophageal cancer	0.00342	0.00345	CcSEcCtD
Anidulafungin—Hypotension—Cisplatin—esophageal cancer	0.00342	0.00344	CcSEcCtD
Anidulafungin—Chills—Capecitabine—esophageal cancer	0.00341	0.00343	CcSEcCtD
Anidulafungin—Mental disorder—Capecitabine—esophageal cancer	0.00333	0.00335	CcSEcCtD
Anidulafungin—Malnutrition—Capecitabine—esophageal cancer	0.00331	0.00333	CcSEcCtD
Anidulafungin—Erythema—Capecitabine—esophageal cancer	0.00331	0.00333	CcSEcCtD
Anidulafungin—Neutropenia—Methotrexate—esophageal cancer	0.0033	0.00333	CcSEcCtD
Anidulafungin—Dyspnoea—Cisplatin—esophageal cancer	0.00326	0.00329	CcSEcCtD
Anidulafungin—Back pain—Capecitabine—esophageal cancer	0.0032	0.00322	CcSEcCtD
Anidulafungin—Pneumonia—Methotrexate—esophageal cancer	0.00317	0.00319	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00316	0.00318	CcSEcCtD
Anidulafungin—Infestation NOS—Methotrexate—esophageal cancer	0.00315	0.00317	CcSEcCtD
Anidulafungin—Infestation—Methotrexate—esophageal cancer	0.00315	0.00317	CcSEcCtD
Anidulafungin—Depression—Methotrexate—esophageal cancer	0.00314	0.00316	CcSEcCtD
Anidulafungin—Vision blurred—Capecitabine—esophageal cancer	0.00312	0.00314	CcSEcCtD
Anidulafungin—Anaemia—Capecitabine—esophageal cancer	0.00306	0.00308	CcSEcCtD
Anidulafungin—Feeling abnormal—Cisplatin—esophageal cancer	0.00302	0.00304	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00298	0.003	CcSEcCtD
Anidulafungin—Leukopenia—Capecitabine—esophageal cancer	0.00296	0.00298	CcSEcCtD
Anidulafungin—Body temperature increased—Cisplatin—esophageal cancer	0.00289	0.00291	CcSEcCtD
Anidulafungin—Cough—Capecitabine—esophageal cancer	0.00289	0.0029	CcSEcCtD
Anidulafungin—Hypertension—Capecitabine—esophageal cancer	0.00286	0.00287	CcSEcCtD
Anidulafungin—Chest pain—Capecitabine—esophageal cancer	0.00282	0.00283	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.0028	0.00281	CcSEcCtD
Anidulafungin—Urinary tract disorder—Methotrexate—esophageal cancer	0.00279	0.00281	CcSEcCtD
Anidulafungin—Urethral disorder—Methotrexate—esophageal cancer	0.00277	0.00279	CcSEcCtD
Anidulafungin—Visual impairment—Methotrexate—esophageal cancer	0.00273	0.00274	CcSEcCtD
Anidulafungin—Confusional state—Capecitabine—esophageal cancer	0.00272	0.00274	CcSEcCtD
Anidulafungin—Hypersensitivity—Cisplatin—esophageal cancer	0.0027	0.00272	CcSEcCtD
Anidulafungin—Infection—Capecitabine—esophageal cancer	0.00268	0.0027	CcSEcCtD
Anidulafungin—Nervous system disorder—Capecitabine—esophageal cancer	0.00265	0.00266	CcSEcCtD
Anidulafungin—Eye disorder—Methotrexate—esophageal cancer	0.00264	0.00266	CcSEcCtD
Anidulafungin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00264	0.00266	CcSEcCtD
Anidulafungin—Cardiac disorder—Methotrexate—esophageal cancer	0.00262	0.00264	CcSEcCtD
Anidulafungin—Skin disorder—Capecitabine—esophageal cancer	0.00262	0.00264	CcSEcCtD
Anidulafungin—Hyperhidrosis—Capecitabine—esophageal cancer	0.00261	0.00263	CcSEcCtD
Anidulafungin—Angiopathy—Methotrexate—esophageal cancer	0.00257	0.00258	CcSEcCtD
Anidulafungin—Immune system disorder—Methotrexate—esophageal cancer	0.00255	0.00257	CcSEcCtD
Anidulafungin—Mediastinal disorder—Methotrexate—esophageal cancer	0.00255	0.00257	CcSEcCtD
Anidulafungin—Chills—Methotrexate—esophageal cancer	0.00254	0.00255	CcSEcCtD
Anidulafungin—Hypotension—Capecitabine—esophageal cancer	0.00252	0.00254	CcSEcCtD
Anidulafungin—Diarrhoea—Cisplatin—esophageal cancer	0.00251	0.00252	CcSEcCtD
Anidulafungin—Mental disorder—Methotrexate—esophageal cancer	0.00248	0.00249	CcSEcCtD
Anidulafungin—Erythema—Methotrexate—esophageal cancer	0.00246	0.00248	CcSEcCtD
Anidulafungin—Malnutrition—Methotrexate—esophageal cancer	0.00246	0.00248	CcSEcCtD
Anidulafungin—Insomnia—Capecitabine—esophageal cancer	0.00244	0.00246	CcSEcCtD
Anidulafungin—Dyspnoea—Capecitabine—esophageal cancer	0.00241	0.00242	CcSEcCtD
Anidulafungin—Back pain—Methotrexate—esophageal cancer	0.00238	0.0024	CcSEcCtD
Anidulafungin—Dyspepsia—Capecitabine—esophageal cancer	0.00238	0.00239	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00233	0.00235	CcSEcCtD
Anidulafungin—Vomiting—Cisplatin—esophageal cancer	0.00233	0.00234	CcSEcCtD
Anidulafungin—Vision blurred—Methotrexate—esophageal cancer	0.00232	0.00234	CcSEcCtD
Anidulafungin—Rash—Cisplatin—esophageal cancer	0.00231	0.00232	CcSEcCtD
Anidulafungin—Constipation—Capecitabine—esophageal cancer	0.00231	0.00232	CcSEcCtD
Anidulafungin—Dermatitis—Cisplatin—esophageal cancer	0.00231	0.00232	CcSEcCtD
Anidulafungin—Anaemia—Methotrexate—esophageal cancer	0.00228	0.00229	CcSEcCtD
Anidulafungin—Feeling abnormal—Capecitabine—esophageal cancer	0.00222	0.00224	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00221	0.00222	CcSEcCtD
Anidulafungin—Leukopenia—Methotrexate—esophageal cancer	0.0022	0.00222	CcSEcCtD
Anidulafungin—Nausea—Cisplatin—esophageal cancer	0.00217	0.00219	CcSEcCtD
Anidulafungin—Cough—Methotrexate—esophageal cancer	0.00215	0.00216	CcSEcCtD
Anidulafungin—Urticaria—Capecitabine—esophageal cancer	0.00214	0.00216	CcSEcCtD
Anidulafungin—Body temperature increased—Capecitabine—esophageal cancer	0.00213	0.00215	CcSEcCtD
Anidulafungin—Abdominal pain—Capecitabine—esophageal cancer	0.00213	0.00215	CcSEcCtD
Anidulafungin—Convulsion—Methotrexate—esophageal cancer	0.00213	0.00215	CcSEcCtD
Anidulafungin—Chest pain—Methotrexate—esophageal cancer	0.0021	0.00211	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00208	0.0021	CcSEcCtD
Anidulafungin—Confusional state—Methotrexate—esophageal cancer	0.00203	0.00204	CcSEcCtD
Anidulafungin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00201	0.00202	CcSEcCtD
Anidulafungin—Infection—Methotrexate—esophageal cancer	0.002	0.00201	CcSEcCtD
Anidulafungin—Hypersensitivity—Capecitabine—esophageal cancer	0.00199	0.002	CcSEcCtD
Anidulafungin—Nervous system disorder—Methotrexate—esophageal cancer	0.00197	0.00198	CcSEcCtD
Anidulafungin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00197	0.00198	CcSEcCtD
Anidulafungin—Skin disorder—Methotrexate—esophageal cancer	0.00195	0.00196	CcSEcCtD
Anidulafungin—Hyperhidrosis—Methotrexate—esophageal cancer	0.00194	0.00196	CcSEcCtD
Anidulafungin—Pruritus—Capecitabine—esophageal cancer	0.00191	0.00192	CcSEcCtD
Anidulafungin—Hypotension—Methotrexate—esophageal cancer	0.00188	0.00189	CcSEcCtD
Anidulafungin—Diarrhoea—Capecitabine—esophageal cancer	0.00185	0.00186	CcSEcCtD
Anidulafungin—Insomnia—Methotrexate—esophageal cancer	0.00182	0.00183	CcSEcCtD
Anidulafungin—Dyspnoea—Methotrexate—esophageal cancer	0.00179	0.0018	CcSEcCtD
Anidulafungin—Dizziness—Capecitabine—esophageal cancer	0.00178	0.0018	CcSEcCtD
Anidulafungin—Dyspepsia—Methotrexate—esophageal cancer	0.00177	0.00178	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00173	0.00175	CcSEcCtD
Anidulafungin—Vomiting—Capecitabine—esophageal cancer	0.00172	0.00173	CcSEcCtD
Anidulafungin—Rash—Capecitabine—esophageal cancer	0.0017	0.00171	CcSEcCtD
Anidulafungin—Dermatitis—Capecitabine—esophageal cancer	0.0017	0.00171	CcSEcCtD
Anidulafungin—Headache—Capecitabine—esophageal cancer	0.00169	0.0017	CcSEcCtD
Anidulafungin—Feeling abnormal—Methotrexate—esophageal cancer	0.00166	0.00167	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00164	0.00165	CcSEcCtD
Anidulafungin—Nausea—Capecitabine—esophageal cancer	0.0016	0.00161	CcSEcCtD
Anidulafungin—Urticaria—Methotrexate—esophageal cancer	0.0016	0.00161	CcSEcCtD
Anidulafungin—Abdominal pain—Methotrexate—esophageal cancer	0.00159	0.0016	CcSEcCtD
Anidulafungin—Body temperature increased—Methotrexate—esophageal cancer	0.00159	0.0016	CcSEcCtD
Anidulafungin—Hypersensitivity—Methotrexate—esophageal cancer	0.00148	0.00149	CcSEcCtD
Anidulafungin—Pruritus—Methotrexate—esophageal cancer	0.00142	0.00143	CcSEcCtD
Anidulafungin—Diarrhoea—Methotrexate—esophageal cancer	0.00137	0.00138	CcSEcCtD
Anidulafungin—Dizziness—Methotrexate—esophageal cancer	0.00133	0.00134	CcSEcCtD
Anidulafungin—Vomiting—Methotrexate—esophageal cancer	0.00128	0.00129	CcSEcCtD
Anidulafungin—Rash—Methotrexate—esophageal cancer	0.00127	0.00128	CcSEcCtD
Anidulafungin—Dermatitis—Methotrexate—esophageal cancer	0.00127	0.00127	CcSEcCtD
Anidulafungin—Headache—Methotrexate—esophageal cancer	0.00126	0.00127	CcSEcCtD
Anidulafungin—Nausea—Methotrexate—esophageal cancer	0.00119	0.0012	CcSEcCtD
